Clinical Outcomes in Patients With Bacteremia and Concomitant Left Ventricular Assist Devices and Cardiac Implantable Electronic Devices. Posted on May 8th, 2023 by LEADconnection Post navigation Previous: Employment of the Evolution RL sheath as a first-choice device shortens transvenous lead extraction time without affecting procedural safety and efficacy compared to its auxiliary use: Insights from the prospective multicenter EVO registry.Next: Quality of life of children and young adults with and without cardiovascular implantable electronic devices during the COVID-19 pandemic.
Employment of the Evolution RL sheath as a first-choice device shortens transvenous lead extraction time without affecting procedural safety and efficacy compared to its auxiliary use: Insights from the prospective multicenter EVO registry. Posted on May 8th, 2023 by LEADconnection Post navigation Previous: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.Next: Clinical Outcomes in Patients With Bacteremia and Concomitant Left Ventricular Assist Devices and Cardiac Implantable Electronic Devices.
Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections. Posted on May 8th, 2023 by LEADconnection Post navigation Previous: Incomplete Lead Removal During the Extraction Procedure: Predisposing Factors and Impact on Long-Term Survival in Infectious and Non-Infectious Cases: Analysis of 3741 ProceduresNext: Employment of the Evolution RL sheath as a first-choice device shortens transvenous lead extraction time without affecting procedural safety and efficacy compared to its auxiliary use: Insights from the prospective multicenter EVO registry.
